NDC 0363-1606 – Fexofenadine HCl and Pseudoephedrine HCI

Fexofenadine Hydrochloride 60 mg/1; Pseudoephedrine Hydrochloride 120 mg/1 · Tablet, Extended Release · Oral

Human Otc Drug 1 recall

Product NDC0363-1606

Product details

Brand name
Fexofenadine HCl and Pseudoephedrine HCI
Generic name
Fexofenadine HCl and Pseudoephedrine HCI
Labeler
Walgreens Company
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA076667
Marketed since
September 16, 2019
Listing expires
December 31, 2026
Pharmacologic class
Histamine-1 Receptor Antagonist; alpha-Adrenergic Agonist

Active ingredients

Uses, dosage, side effects and warnings for Fexofenadine HCl and Pseudoephedrine HCI →

Package NDC codes (2)

Package NDCDescriptionSince
0363-1606-204 BLISTER PACK in 1 CARTON (0363-1606-20) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACKSep 16, 2019
0363-1606-306 BLISTER PACK in 1 CARTON (0363-1606-30) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACKSep 16, 2019

Recalls mentioning this NDC

Other Fexofenadine HCl and Pseudoephedrine HCI products